Cargando…

Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials

PURPOSE: We aimed to establish correlations between the clinical features of a cohort of Usher syndrome (USH) patients with pathogenic variants in MYO7A, type of pathogenic variant, and location on the protein domain. METHODS: Sixty‐two USH patients from 46 families with biallelic variants in MYO7A...

Descripción completa

Detalles Bibliográficos
Autores principales: Galbis‐Martínez, Lilián, Blanco‐Kelly, Fiona, García‐García, Gema, Ávila‐Fernández, Almudena, Jaijo, Teresa, Fuster‐García, Carla, Perea‐Romero, Irene, Zurita‐Muñoz, Olga, Jimenez‐Rolando, Belén, Carreño, Ester, García‐Sandoval, Blanca, Millán, José M., Ayuso, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540557/
https://www.ncbi.nlm.nih.gov/pubmed/33576163
http://dx.doi.org/10.1111/aos.14795
_version_ 1784803733319712768
author Galbis‐Martínez, Lilián
Blanco‐Kelly, Fiona
García‐García, Gema
Ávila‐Fernández, Almudena
Jaijo, Teresa
Fuster‐García, Carla
Perea‐Romero, Irene
Zurita‐Muñoz, Olga
Jimenez‐Rolando, Belén
Carreño, Ester
García‐Sandoval, Blanca
Millán, José M.
Ayuso, Carmen
author_facet Galbis‐Martínez, Lilián
Blanco‐Kelly, Fiona
García‐García, Gema
Ávila‐Fernández, Almudena
Jaijo, Teresa
Fuster‐García, Carla
Perea‐Romero, Irene
Zurita‐Muñoz, Olga
Jimenez‐Rolando, Belén
Carreño, Ester
García‐Sandoval, Blanca
Millán, José M.
Ayuso, Carmen
author_sort Galbis‐Martínez, Lilián
collection PubMed
description PURPOSE: We aimed to establish correlations between the clinical features of a cohort of Usher syndrome (USH) patients with pathogenic variants in MYO7A, type of pathogenic variant, and location on the protein domain. METHODS: Sixty‐two USH patients from 46 families with biallelic variants in MYO7A were examined for visual and audiological features. Participants were evaluated based on self‐reported ophthalmological history and ophthalmological investigations (computerized visual field testing, best‐corrected visual acuity, and ophthalmoscopic and electrophysiological examination). Optical coherence tomography and fundus autofluorescence imaging were performed when possible. Auditory and vestibular functions were evaluated. Patients were classified according to the type of variant and the protein domain where the variants were located. RESULTS: Most patients displayed a typical USH1 phenotype, that is, prelingual severe‐profound sensorineural hearing loss, prepubertal retinitis pigmentosa (RP) and vestibular dysfunction. No statistically significant differences were observed for the variables analysed except for the onset of hearing loss due to the existence of two USH2 cases, defined as postlingual sensorineural hearing loss, postpubertal onset of RP, and absence of vestibular dysfunction, and one atypical case of USH. CONCLUSION: We were unable to find a correlation between genotype and phenotype for MYO7A. However, our findings could prove useful for the assessment of efficacy in clinical trials, since the type of MYO7A variant does not seem to change the onset, severity or course of visual disease.
format Online
Article
Text
id pubmed-9540557
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95405572022-10-14 Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials Galbis‐Martínez, Lilián Blanco‐Kelly, Fiona García‐García, Gema Ávila‐Fernández, Almudena Jaijo, Teresa Fuster‐García, Carla Perea‐Romero, Irene Zurita‐Muñoz, Olga Jimenez‐Rolando, Belén Carreño, Ester García‐Sandoval, Blanca Millán, José M. Ayuso, Carmen Acta Ophthalmol Original Articles PURPOSE: We aimed to establish correlations between the clinical features of a cohort of Usher syndrome (USH) patients with pathogenic variants in MYO7A, type of pathogenic variant, and location on the protein domain. METHODS: Sixty‐two USH patients from 46 families with biallelic variants in MYO7A were examined for visual and audiological features. Participants were evaluated based on self‐reported ophthalmological history and ophthalmological investigations (computerized visual field testing, best‐corrected visual acuity, and ophthalmoscopic and electrophysiological examination). Optical coherence tomography and fundus autofluorescence imaging were performed when possible. Auditory and vestibular functions were evaluated. Patients were classified according to the type of variant and the protein domain where the variants were located. RESULTS: Most patients displayed a typical USH1 phenotype, that is, prelingual severe‐profound sensorineural hearing loss, prepubertal retinitis pigmentosa (RP) and vestibular dysfunction. No statistically significant differences were observed for the variables analysed except for the onset of hearing loss due to the existence of two USH2 cases, defined as postlingual sensorineural hearing loss, postpubertal onset of RP, and absence of vestibular dysfunction, and one atypical case of USH. CONCLUSION: We were unable to find a correlation between genotype and phenotype for MYO7A. However, our findings could prove useful for the assessment of efficacy in clinical trials, since the type of MYO7A variant does not seem to change the onset, severity or course of visual disease. John Wiley and Sons Inc. 2021-02-11 2021-12 /pmc/articles/PMC9540557/ /pubmed/33576163 http://dx.doi.org/10.1111/aos.14795 Text en © 2021 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Galbis‐Martínez, Lilián
Blanco‐Kelly, Fiona
García‐García, Gema
Ávila‐Fernández, Almudena
Jaijo, Teresa
Fuster‐García, Carla
Perea‐Romero, Irene
Zurita‐Muñoz, Olga
Jimenez‐Rolando, Belén
Carreño, Ester
García‐Sandoval, Blanca
Millán, José M.
Ayuso, Carmen
Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials
title Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials
title_full Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials
title_fullStr Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials
title_full_unstemmed Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials
title_short Genotype–phenotype correlation in patients with Usher syndrome and pathogenic variants in MYO7A: implications for future clinical trials
title_sort genotype–phenotype correlation in patients with usher syndrome and pathogenic variants in myo7a: implications for future clinical trials
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540557/
https://www.ncbi.nlm.nih.gov/pubmed/33576163
http://dx.doi.org/10.1111/aos.14795
work_keys_str_mv AT galbismartinezlilian genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials
AT blancokellyfiona genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials
AT garciagarciagema genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials
AT avilafernandezalmudena genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials
AT jaijoteresa genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials
AT fustergarciacarla genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials
AT perearomeroirene genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials
AT zuritamunozolga genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials
AT jimenezrolandobelen genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials
AT carrenoester genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials
AT garciasandovalblanca genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials
AT millanjosem genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials
AT ayusocarmen genotypephenotypecorrelationinpatientswithushersyndromeandpathogenicvariantsinmyo7aimplicationsforfutureclinicaltrials